Fig. 3From: Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient micePDX-IM applications in cancer therapy, such as screening and evaluation of drugs, bioinformatics databases, diagnosis of biomarkers and sensitive indicators, co-clinical trials (mechanisms of drug resistance), metastasis of malignant tumors, precision medicine, and immunotherapyBack to article page